The Personalization of Therapy: Molecular Profiling Technologies and Their Application

Area of Science:

• Oncology
• Human Genetics
• Biotechnology

Background:

• Personalized oncology leverages advances in tumor biology and genetics to identify driver events and critical dependencies.
• Targeted therapies are increasingly effective in molecularly selected patient populations, shifting clinical practice.
• Molecular profiling is becoming standard in oncology for clinical decision-making.

Purpose of the Study:

• To summarize biomarker applications in personalized oncology.
• To discuss current challenges in biomarker identification.
• To review major technologies used in clinical practice for molecular analysis.

Main Methods:

• Review of current literature on biomarker applications in oncology.
• Discussion of next-generation sequencing and other molecular analysis platforms.
• Analysis of technologies enabling high-degree multiplexing for targeted therapies.

Main Results:

• Actionable biomarkers are key to matching patients with specific targeted therapies.
• Biotechnology and next-generation sequencing have rapidly evolved molecular analysis platforms.
• High-throughput molecular analysis facilitates the transformation of targeted therapy use.

Conclusions:

• Accurate and reliable biomarker identification is essential for personalized oncology.
• Technological advancements are critical for the successful implementation of targeted therapies.
• Continued evolution of molecular profiling technologies will further advance cancer treatment.